Structure de mise en forme 2 colonnes

SPECIFIC INHIBITION OF THE REDOX ACTIVITY OF THE MULTIFUNCTIONAL APE1/REF-1 PROTEIN BY E3330 BLOCKS TNF-A-INDUCED ACTIVATION OF IL-8 PRODUCTION IN HEPATIC CELL LINES
46th Annual Meeting of the European Association for the Study of the Liver (EASL), Berlin,  2011
E. Codarin1*, L. Cesaratto1,2, A. Caragnano1, S. Bellentani2,3, M.R. Kelley4, C. Tiribelli2, G. Tell1

RESISTANCE EXERCISE IMPROVES LIVER LIPID, FAT OXIDATION AND GLUCOSE CONTROL IN ADULTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE INDEPENDENT OF WEIGHT LOSS
EASL 2011 
K. Hallsworth1,2*, G. Fattakhova1, K. Hollingsworth1, C. Thoma1,2, S. Moore1,2, R. Taylor1, C.P. Day1, M.I. Trenell1,2

NAFLD AND THE CHANGING FACE OF HEPATOCELLULAR CANCER (HCC)
EASL 2011
D. Das1, D. Chattopadyhay1,2, I. Patanwala1, T. Islam1, D. Walia1, J. Rose3, B. Jaques4, D.M. Manas4, M. Hudson1, H.L. Reeves2* 

PROGRESSION OF NAFLD IN HUMANS IS ASSOCIATED WITH THE ACTIVATION OF THE RENIN-ANGIOTENSIN SYSTEM
EASL 2011
J. Vergniol1*, V. Barbu2, M. Lemoine3, D. Wendum2, C. Chatzantoniou4, L. Serfaty3, C. Housset3, V. Ratziu5 

NEW METHODOLOGY FOR ASSESSING PROGRESSION OF LIVER FIBROSIS IN LARGE POPULATIONS USING VALIDATED BIOMARKER FIBROTEST® INSTEAD OF BIOPSY
EASL 2011
T. Poynard1*, M. Munteanu2, O. Deckmyn2, Y. Ngo2, F. Drane2, J.M. Castille2, C. Housset1, V. Ratziu1, F. Imbert-Bismut1

THE HAZARDS OF TRANSAMINASE ALT VALUE AS A MARKER OF LIVER FIBROSIS PROGRESSION: A GLOBAL ASSESSMENT IN PATIENTS USING VALIDATED BIOMARKER FIBROTEST®
EASL 2011
T. Poynard1*, M. Munteanu2, O. Deckmyn2, Y. Ngo2, F. Drane2, J.M. Castille2, C. Housset3, V. Ratziu1, F. Imbert-Bismut1 

Fibroblast growth factor 21 is a predictor of advanced disease in patients with NAFLD
AASLD 2011
Raluca Pais1, Randa Bittar1, Lyudmila Mateeva2, Dan Dumitrascu3, Larissa Fedchuk1, Thierry Poynard1, Dominique Bonnefont-Rousselot1, Vlad Ratziu1

Validation of a simple algorithm combining serum markers and elastometry for the diagnosis of fibrosis in NAFLD
AASLD 2011
Raluca Pais, Pascal Lebray, Laryssa Fedchuck, Fréderic Charlotte, Thierry Poynard, Vlad Ratziu

DIAGNOSTIC VALUE OF BIOMARKERS (FIBROTEST, ACTITEST, STEATOTEST AND NASHTEST) FOR THE PREDICTION OF LIVER INJURY IN 494 PATIENTS WITH SEVERE OBESITY
EASL 2011

T. Poynard1, P. Mathurin2,3, E. Diaz4, K. Clement5, M. Munteanu6*, B. Demol7, F. Pattou8,9, F. Charlotte10, R. Callafe11, A. Hollebecque2,3, V. Ratziu1, FLIP European consortium

To top